Hims & Hers offers rare high growth at value pricing, with DCF models pointing to major upside despite volatility and short ...

RADX READ THE FULL RADX RESEARCH REPORT We are initiating coverage of Radiopharm Theranostics Limited (NASDAQ:RADX) and assign a valuation of $12.50 per American Depository Receipt (ADR). This ...

MACOM Technology is poised for upside with strong exposure to 5G, AI, and photonics, supported by solid products. See why ...

Legal claims are increasingly being considered as an alternative asset class, however, there appears to be a lack of a standard methodology for valuing litigation risk. This paper proposes a dynamic ...

The Financial Conduct Authority (FCA’s) report, which sets out its findings and feedback from its Private Market Valuation ...